2015. ISPOR European Congress – Cost-Effectiveness of Cetuximab in First-Line Treatment of Patients with Metastatic Colorectal Cancer in Belgium and the Netherlands

Krol M, Ovcinnikova O, von Honhorst P, Jarrett J. Cost-Effectiveness of Cetuximab in First-Line Treatment of Patients with Metastatic Colorectal Cancer in Belgium and the Netherlands. Value Health. 2015 Nov;18(7):A464. Presented at: ISPOR 18th Annual European Congress; November 9, 2015; Milan, Italy.